This inventor holds 2 USPTO granted patents. Top assignee: Kabivitrum Ab. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1989
Title: Annelie B Lundin: Innovator in Hemophilia Treatment
Introduction
Annelie B Lundin is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of biotechnology, particularly in the treatment of hemophilia. With a total of 2 patents, her work has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Annelie Lundin's latest patents focus on biologically active fragments of human antihemophilic factor. These patents detail novel, biologically active fragments, processes for their preparation, and pharmaceutical preparations containing them. The use of such fragments is aimed at treating patients suffering from hemophilia, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Annelie has been associated with Kabivitrum AB, where she has played a crucial role in research and development. Her innovative approach and dedication to her work have established her as a key figure in her field.
Collaborations
Annelie has collaborated with notable colleagues, including Lars-Olof Andersson and Nanna Forsman. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Annelie B Lundin's contributions to the field of hemophilia treatment through her patents and collaborations highlight her as a significant innovator in biotechnology. Her work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile